About this trial
This study plans to learn if the EvoEndo Endoscopy system can be used to evaluate, provide and follow up care for upper gastrointestinal tract diseases in the bariatric population. The smallest current scope available for such a technique is an adult transnasal endoscope with a larger diameter, a pulmonary bronchoscope or Ear Nose and Throat (ENT) laryngoscope. This study is evaluating a newly Food and Drug Administration (FDA) cleared ultra-slim, single-use, endoscope specifically designed for transnasal endoscopy to evaluate its use in adult upper tract gastrointestinal diseases. If such a technique is successful it could improve the safety, cost, and access of endoscopic care for patients in need of an endoscopic evaluation for a bariatric medical condition.
Eligibility criteria
Qualifiers
Patient 18 years of age and less than 90 years of age with clinically referred for esophagoscopy, gastroscopy, or esophagogastroduodenoscopy (EGD)
Cared for in metabolic and bariatric clinic
Disqualifiers
Patient <18 years of age
Medically contraindicated to perform EGD or TNE
Inability to provide informed consent
Trial design
Treatments tested in this trial
- Transnasal Endoscopy
- Esophagogastroduodenoscopy
Treatment groups
Sponsors and collaborators
Christopher C. Thompson, MD, MSc
Lead sponsor
Brigham and Women's Hospital
Sponsor institution
EvoEndo, Inc.
Collaborator